Crossmark

Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

Crossref DOI link: https://doi.org/10.1186/s12943-019-0994-2

Published Online: 2019-03-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fiori, Micol Eleonora

Di Franco, Simone

Villanova, Lidia

Bianca, Paola

Stassi, Giorgio

De Maria, Ruggero
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (9979)

Associazione Italiana per la Ricerca sul Cancro (9979)

Associazione Italiana per la Ricerca sul Cancro (IG 16746)

Italian Ministry of Foreign Affairs and International Cooperation & Italian Ministry of Education, University and Research (PGR00674)
License Information

Text and Data Mining valid from 2019-03-30
More Information

Article History

Received: 20 December 2018

Accepted: 28 February 2019

First Online: 30 March 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.